文献速递眼底病与葡萄膜炎

治疗初治增殖性糖尿病视网膜病变的周边毛细血管无灌注与全视网膜光凝后6个月疾病活动相关

Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation.
PubMed 文献 · Br J Ophthalmol · 2018-08-01

这项前瞻性干预研究纳入33只治疗初治的增殖性糖尿病视网膜病变(PDR)眼,在导航激光系统行全视网膜光凝(PRP)前及术后3、6个月进行视网膜血氧测定和超广角荧光素血管造影。6个月时按疾病活动分为活动组与不活动组,活动组在基线和6个月时周边毛细血管无灌注(PCNP)面积均显著大于不活动组,提示基线PCNP面积可能预测PRP后PDR活动。

要点

  • PRP后6个月有疾病活动者基线及6个月PCNP面积均大于不活动者。
  • 两组PCNP面积从基线到6个月均无显著变化。
  • 视网膜血氧饱和度变化未见临床相关性。

核心结论

  • PRP后6个月疾病活动的PDR眼在所有时间点PCNP面积均统计学显著大于不活动眼。
  • 基线PCNP面积可能作为PRP后PDR活动的潜在预测标志物。

研究设计与样本

  • 前瞻性干预研究,纳入33只治疗初治的PDR眼,69.6%为男性。
  • 基线及PRP后3、6个月行视网膜血氧测定和超广角荧光素血管造影。
  • PRP由导航激光系统完成,6个月随访时按疾病活动分为活动组与不活动组。

主要发现

  • 基线中位年龄51.6±23.4岁,糖尿病病程20.0±15.0年,HbA1c 63.0±17.0 mmol/mol,血压152±37/82±24 mm Hg。
  • 术后疾病活动组占30.3%(n=10),其PCNP面积在基线为51%-75%,不活动组为26%-50%(p=0.03)。
  • 6个月时活动组PCNP面积仍为51%-75%,不活动组为26%-50%(p=0.03)。
  • PCNP面积从基线到6个月在两组内均无显著变化(不活动组p=0.38,活动组p=0.87)。
  • 视网膜氧饱和度变化未发现临床相关。

临床怎么用

  • 对治疗初治PDR患者,可关注基线超广角荧光素血管造影显示的PCNP面积以辅助预判PRP后6个月疾病活动风险。
  • PRP后6个月疾病活动与较大PCNP面积相关,提示需个体化随访与治疗规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: With the perspective to provide individualised panretinal laser photocoagulation (PRP) for proliferative diabetic retinopathy (PDR), we evaluated if retinal peripheral capillary non-perfusion (PCNP) and oximetry, as non-invasive markers of retinal metabolism and function, could predict disease activity 6 months after PRP. METHODS: We performed a prospective, interventional study of patients with treatment-naïve PDR. Retinal oximetry and ultra-widefield fluorescein angiography were performed at baseline (BL) and three (3M) and 6 months (6M) after PRP by a navigated laser system. At 6M follow-up, patients were divided according to disease activity: active or inactive. RESULTS: We included 33 eyes, and 69.6% were men. At BL, the median age and duration of diabetes (with IQRs) were 51.6±23.4 and 20.0±15.0 years. Haemoglobin A1c was 63.0±17.0 mmol/mol and blood pressure was 152±37/82±24 mm Hg. At BL and M6, patients with postoperative disease activity (30.3.%, n=10) had a larger area with PCNP than those with inactive PDR (BL: 51%-75% vs 26%-50%, p=0.03; 6M: 51%-75% vs 26%-50%, p=0.03). The area of PCNP did not change from BL to 6M in either group (inactive PDR: p=0.38, active PDR: p=0.87). Changes in retinal oxygen saturation were not found to be clinical relevant. CONCLUSION: We found the area of PCNP at all timepoints to be statistically larger in patients with active PDR 6 months after PRP treatment. Therefore, the area of PCNP, at baseline, may serve as a potential predictive marker for PDR activity after treatment.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Torp TL, Kawasaki R, Wong TY, et al. Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation. Br J Ophthalmol. 2018. PMID: 30068515. doi:10.1136/bjophthalmol-2018-312195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。